Transcode Therapeutics | DEFR14A:修正后委托征集材料
Transcode Therapeutics | 10-Q:季度报表
Transcode Therapeutics | 8-K:重大事件
Transcode Therapeutics | DEFA14A:其他
Transcode Therapeutics | PRE 14A:并购重组委托声明
Transcode Therapeutics | 8-K:重大事件
Transcode Therapeutics | DEF 14A:股东委托书决议
Transcode Therapeutics | ARS:年度报告
Transcode Therapeutics | 8-K:重大事件
Transcode Therapeutics | 8-K:重大事件
Transcode Therapeutics | 10-K:年度报表
Transcode Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Zdravka Medarova(0.4%)
Transcode Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Tang Capital Partners, LP(0.0%),Tang Capital Management, LLC(0.0%)等
Transcode Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Lind Global Fund II LP(0.1%),Lind Global Partners II LLC(0.1%)等
Transcode Therapeutics | 8-K:重大事件
Transcode Therapeutics | 8-K:重大事件
Transcode Therapeutics | 424B4:募资说明书
Transcode Therapeutics | EFFECT:其他
Transcode Therapeutics | S-1/A:证券上市注册声明(修正)
Transcode Therapeutics | CORRESP:信函
暂无数据